Literature DB >> 27201830

Comparison of Methods to Estimate Health State Utilities in Metastatic Breast Cancer (MBC).

S Hudgens1, A Briggs2, G Tremblay3, A Forsythe3, A Lloyd4.   

Abstract

Entities:  

Year:  2014        PMID: 27201830     DOI: 10.1016/j.jval.2014.08.1835

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea.

Authors:  Gabriel Tremblay; Unnati Majethia; Janis L Breeze; Ilias Kontoudis; Jeongae Park
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.